Neurogene
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$36,317,000 over the previous period. Total operating expenses were $55,583,000.
Profit Margin
| 2014 | 0 | -23.82M | |
|---|---|---|---|
| 2015 | 0 | -21.86M | |
| 2017 | 0 | -50.18M | |
| 2019 | 0 | -69.44M | |
| 2020 | 0 | -33.27M | |
| 2021 | 0 | -50.51M | |
| 2022 | 0 | -55.18M | |
| 2023 | 0 | -36.31M |
NGNE Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2017 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 3.26M | 3.19M | 2.27M | 1.82M | 340K | 0 | 0 | 135.94K |
Gross profit | -3.26M | -3.19M | -2.27M | -1.82M | -340K | 0 | 0 | -135.94K |
Operating exp. | ||||||||
Research and development | 44.39M | 47.50M | 42.26M | 24.34M | 6.31M | 36.26M | 15.79M | 17.94M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 55.58M | 56.51M | 50.53M | 39.73M | 24.10M | 51.11M | 21.34M | 22.23M |
Operating income | -55.58M | -56.51M | -50.53M | -41.55M | -24.44M | -51.11M | -21.34M | -22.37M |
Other income (expenses), net | 19.26M | -7K | 17K | 8.27M | -44.99M | 936K | -520K | -1.65M |
Income before tax | -36.31M | -55.18M | -50.51M | -33.27M | -69.44M | -50.18M | -21.86M | -24.02M |
Income tax expense | 0 | -5K | 17K | -1 | 0 | -1 | 0 | -222 |
Net income | -36.31M | -55.18M | -50.51M | -33.27M | -69.44M | -50.18M | -21.86M | -23.82M |
Earnings per share | ||||||||
Basic EPS | -2.83 | -4.3 | -0.92 | -0.64 | -2.57 | -2.14 | -1.73 | -2.75 |
Diluted EPS | -2.83 | -4.3 | -0.92 | -0.64 | -2.57 | -2.14 | -1.73 | -2.75 |
| Data source |